Sharing our perspective

Sharing perspectives leads to greater understanding and fuels innovation. The ​Optum Insights ​blog is where we share our perspective and challenge preconceptions to clear a new path forward.


  • Pennsylvania Takes Steps Forward on Drug Formulary

    by
    • Optum Workers' Comp
    | Feb 17, 2017
    Tag Icon
    Workers' Compensation, Formularies
    The Pennsylvania House Labor and Industry Committee heard testimony on a workers’ compensation drug formulary bill on Wednesday, February 15th. House Bill (HB) 18, sponsored by Rep. Ryan Mackenzie, garnered significant attention from various stakeholders who presented both verbal and written testimony. No action was taken on the legislation at this hearing.


  • Naloxone - Take Home Products Offer New Doses

    by
    • Optum Workers' Comp
    | Jan 27, 2017
    Tag Icon
    Naloxone, FDA, Overdose, Opioids
    Two major pharmaceutical manufacturers have been approved by the United States Food and Drug Administration (FDA) to market new strengths of their naloxone products. Narcan® Nasal Spray and Evzio® auto-injector are indicated for the emergency treatment of opioid overdose, as manifested by respiratory and/or central nervous system depression.


  • New Hampshire and Vermont Implement New Opioid Requirements

    by
    • Optum Workers' Comp
    | Jan 12, 2017
    Tag Icon
    Chronic Pain, Opioids, PDMPs
    New Hampshire Board of Medicine and Vermont Department of Health adopt new opioid rules. Read more here.


  • FDA Approval Alert: Long-Acting Opioid Painkiller Wins FDA Approval

    by
    • Optum Workers' Comp
    | Jan 11, 2017
    Tag Icon
    Opioids, FDA
    In August 2016, we reported ArymoTM ER had gained approval from a Food and Drug Administration (FDA) advisory committee to approve the abuse-deterrent, long-acting opioid.






Subscribe

Stay informed by signing up to receive newsletters, alerts, insights and videos.
You can customize your content preferences after you subscribe.